DK3658133T3 - Sammensætninger omfattende aminosyrer til anvendelse ved behandling af fedme - Google Patents
Sammensætninger omfattende aminosyrer til anvendelse ved behandling af fedme Download PDFInfo
- Publication number
- DK3658133T3 DK3658133T3 DK18753466.4T DK18753466T DK3658133T3 DK 3658133 T3 DK3658133 T3 DK 3658133T3 DK 18753466 T DK18753466 T DK 18753466T DK 3658133 T3 DK3658133 T3 DK 3658133T3
- Authority
- DK
- Denmark
- Prior art keywords
- obesity
- compositions
- treatment
- amino acids
- acids
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000087376A IT201700087376A1 (it) | 2017-07-28 | 2017-07-28 | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| PCT/IB2018/055428 WO2019021137A1 (en) | 2017-07-28 | 2018-07-20 | COMPOSITIONS COMPRISING AMINO ACIDS FOR USE IN THE TREATMENT OF DISEASES RELATED TO MITOCHONDRIAL DYSFUNCTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3658133T3 true DK3658133T3 (da) | 2022-07-04 |
Family
ID=60628071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18753466.4T DK3658133T3 (da) | 2017-07-28 | 2018-07-20 | Sammensætninger omfattende aminosyrer til anvendelse ved behandling af fedme |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11452702B2 (da) |
| EP (1) | EP3658133B1 (da) |
| JP (1) | JP7244184B2 (da) |
| KR (1) | KR102602041B1 (da) |
| CN (1) | CN110996936A (da) |
| AU (1) | AU2018307712B2 (da) |
| BR (1) | BR112020001480A2 (da) |
| CA (1) | CA3070199A1 (da) |
| CL (1) | CL2020000221A1 (da) |
| DK (1) | DK3658133T3 (da) |
| ES (1) | ES2921908T3 (da) |
| HU (1) | HUE059500T2 (da) |
| IT (1) | IT201700087376A1 (da) |
| LT (1) | LT3658133T (da) |
| MX (1) | MX2020001084A (da) |
| MY (1) | MY200739A (da) |
| PH (1) | PH12020500189A1 (da) |
| PL (1) | PL3658133T3 (da) |
| PT (1) | PT3658133T (da) |
| RS (1) | RS63392B1 (da) |
| SG (1) | SG11201912098SA (da) |
| WO (1) | WO2019021137A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700087359A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| IT201900002109A1 (it) * | 2019-02-13 | 2020-08-13 | Professional Dietetics Spa | Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale |
| IT202000000454A1 (it) | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10000577A1 (de) | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| ITTO20010804A1 (it) | 2001-08-08 | 2003-02-08 | Professional Dietetics Srl | Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl |
| ITTO20030789A1 (it) | 2003-10-07 | 2005-04-08 | Professional Dietetics Srl | Composizione a base di amino acidi per il trattamento |
| CN103702572A (zh) * | 2011-06-23 | 2014-04-02 | 因诺瓦食品公司 | 改进的食品组合物 |
| US9198454B2 (en) * | 2012-03-08 | 2015-12-01 | Nusirt Sciences, Inc. | Compositions, methods, and kits for regulating energy metabolism |
| US9597367B2 (en) * | 2013-04-19 | 2017-03-21 | Bioventures, Llc | Methods for improving muscle and heart function |
| PL3006027T3 (pl) * | 2014-10-08 | 2018-02-28 | Professional Dietetics S.P.A. | Kompozycje zawierające aminokwasy do stosowania w leczeniu ogólnoustrojowego stanu zapalnego związanego z udarem u pacjentów z dysfagią |
| US10226441B2 (en) | 2014-12-09 | 2019-03-12 | Nihon Sizen Hakkoh Co., Ltd. | Aging inhibitor |
| MX357998B (es) | 2015-03-20 | 2018-07-11 | Antonio Hernandez Miramontes Jorge | Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo. |
| CN107708683A (zh) | 2015-05-11 | 2018-02-16 | 纽卡斯尔创新有限公司 | 氨基酸补充 |
| JP6773269B2 (ja) | 2015-05-14 | 2020-10-21 | プロフェッショナル ダイエテティクス エス．ピー．エー． | 放射線療法および／または化学療法を受けている腫瘍患者における粘膜炎の治療における使用のためのアミノ酸を備える組成物 |
| WO2017020121A1 (en) * | 2015-07-31 | 2017-02-09 | Val-Chum, Limited Partnership | Glycerol-3-phosphate phosphatase activators |
| RU2741637C2 (ru) * | 2015-11-27 | 2021-01-28 | Даблгуд Аб | Пищевая добавка и композиция для лечения метаболического синдрома |
| CN105851758A (zh) * | 2016-05-18 | 2016-08-17 | 何凤祥 | 氨基酸饮品 |
| IT201700087359A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| IT201800006725A1 (it) | 2018-06-27 | 2019-12-27 | Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche |
-
2017
- 2017-07-28 IT IT102017000087376A patent/IT201700087376A1/it unknown
-
2018
- 2018-07-20 KR KR1020207003493A patent/KR102602041B1/ko active IP Right Grant
- 2018-07-20 ES ES18753466T patent/ES2921908T3/es active Active
- 2018-07-20 MX MX2020001084A patent/MX2020001084A/es unknown
- 2018-07-20 AU AU2018307712A patent/AU2018307712B2/en active Active
- 2018-07-20 BR BR112020001480-0A patent/BR112020001480A2/pt unknown
- 2018-07-20 PL PL18753466.4T patent/PL3658133T3/pl unknown
- 2018-07-20 CA CA3070199A patent/CA3070199A1/en active Pending
- 2018-07-20 DK DK18753466.4T patent/DK3658133T3/da active
- 2018-07-20 HU HUE18753466A patent/HUE059500T2/hu unknown
- 2018-07-20 WO PCT/IB2018/055428 patent/WO2019021137A1/en active Application Filing
- 2018-07-20 CN CN201880048060.7A patent/CN110996936A/zh active Pending
- 2018-07-20 LT LTEPPCT/IB2018/055428T patent/LT3658133T/lt unknown
- 2018-07-20 RS RS20220607A patent/RS63392B1/sr unknown
- 2018-07-20 MY MYPI2020000104A patent/MY200739A/en unknown
- 2018-07-20 PT PT187534664T patent/PT3658133T/pt unknown
- 2018-07-20 SG SG11201912098SA patent/SG11201912098SA/en unknown
- 2018-07-20 EP EP18753466.4A patent/EP3658133B1/en active Active
- 2018-07-20 US US16/634,424 patent/US11452702B2/en active Active
- 2018-07-20 JP JP2019566744A patent/JP7244184B2/ja active Active
-
2020
- 2020-01-27 PH PH12020500189A patent/PH12020500189A1/en unknown
- 2020-01-27 CL CL2020000221A patent/CL2020000221A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018307712A1 (en) | 2020-02-13 |
| SG11201912098SA (en) | 2020-01-30 |
| RU2019141226A3 (da) | 2021-10-07 |
| MY200739A (en) | 2024-01-13 |
| KR102602041B1 (ko) | 2023-11-14 |
| WO2019021137A1 (en) | 2019-01-31 |
| LT3658133T (lt) | 2022-08-10 |
| HUE059500T2 (hu) | 2022-11-28 |
| PL3658133T3 (pl) | 2022-07-25 |
| PT3658133T (pt) | 2022-07-08 |
| CL2020000221A1 (es) | 2020-07-31 |
| US11452702B2 (en) | 2022-09-27 |
| CA3070199A1 (en) | 2019-01-31 |
| EP3658133A1 (en) | 2020-06-03 |
| ES2921908T3 (es) | 2022-09-02 |
| AU2018307712B2 (en) | 2023-11-09 |
| MX2020001084A (es) | 2022-08-26 |
| CN110996936A (zh) | 2020-04-10 |
| EP3658133B1 (en) | 2022-04-06 |
| BR112020001480A2 (pt) | 2020-09-08 |
| KR20200033873A (ko) | 2020-03-30 |
| PH12020500189A1 (en) | 2020-09-14 |
| IT201700087376A1 (it) | 2019-01-28 |
| RU2019141226A (ru) | 2021-08-30 |
| JP7244184B2 (ja) | 2023-03-22 |
| JP2020528402A (ja) | 2020-09-24 |
| RS63392B1 (sr) | 2022-08-31 |
| US20200253906A1 (en) | 2020-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
| DK3490582T3 (da) | Sammensætninger til anvendelse i behandling af myelofibrose | |
| DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
| DK3119797T3 (da) | Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose | |
| DK3096798T3 (da) | Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem | |
| DK3658132T3 (da) | Sammensætninger omfattende aminosyrer til anvendelse ved behandling af mitokondrielle dysfunktion-relaterede sygdomme | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3185957T3 (da) | Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis | |
| DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3522904T3 (da) | Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux | |
| DK3226854T3 (da) | Aminosyrebaseret sammensætning til genoprettelse af fibroelastin i hudens bindevæv | |
| DK3310190T3 (da) | Sammensætning til behandling af kød og anvendelse af denne | |
| RS65701B1 (sr) | Kompozicije za upotrebu u lečenju hipertenzije | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| DK3478713T3 (da) | Sammensætninger til behandling af amyloidose | |
| DK3586837T3 (da) | Sammensætninger omfattende aminosyrer til anvendelse ved forebyggelse og behandling af leversygdomme | |
| DK3442558T3 (da) | Bmp-7-afledte peptider til anvendelse i behandlingen af osteoartritis | |
| DK3506901T3 (da) | Anvendelse af kynurensyre til behandling af muskelatrofi | |
| DK3423060T3 (da) | Imatinib til anvendelse til behandling af slagtilfælde | |
| DK3658133T3 (da) | Sammensætninger omfattende aminosyrer til anvendelse ved behandling af fedme | |
| DK3283064T3 (da) | Derivater til anvendelse i behandling af muskelatrofi | |
| DK3220908T3 (da) | Sammensætninger og fremgangsmåder til behandling af endometriose | |
| DK3373922T3 (da) | Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri | |
| DK3773615T3 (da) | Flydende sammensætning til anvendelse ved behandling af slimhinden i munden-svælget-struben-spiserøret |